Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE-AD: Prazosin for Agitation in Alzheimer's
NCT03710642Phase 2Completed
- Sponsor
- Alzheimer's Disease Cooperative Study
- Start
- Oct 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prazosin in Alzheimer's disease (AD), sponsored by Alzheimer's Disease Cooperative Study. Started Oct 2018; status: completed.
02
Drugs
prazosin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03710642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710642.